1. Home
  2. BBW vs KLTOW Comparison

BBW vs KLTOW Comparison

Compare BBW & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Build-A-Bear Workshop Inc.

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$61.19

Market Cap

696.0M

ML Signal

HOLD

Logo Klotho Neurosciences Inc. Warrant

KLTOW

Klotho Neurosciences Inc. Warrant

HOLD

Current Price

$0.11

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBW
KLTOW
Founded
1997
N/A
Country
United States
United States
Employees
N/A
3
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
696.0M
N/A
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
BBW
KLTOW
Price
$61.19
$0.11
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$67.71
N/A
AVG Volume (30 Days)
526.5K
N/A
Earning Date
12-04-2025
N/A
Dividend Yield
1.41%
N/A
EPS Growth
15.02
N/A
EPS
4.36
N/A
Revenue
$525,767,000.00
N/A
Revenue This Year
$8.05
N/A
Revenue Next Year
$4.31
N/A
P/E Ratio
$14.31
N/A
Revenue Growth
6.17
N/A
52 Week Low
$32.55
N/A
52 Week High
$75.85
N/A

Technical Indicators

Market Signals
Indicator
BBW
KLTOW
Relative Strength Index (RSI) 69.52 50.43
Support Level $53.01 $0.10
Resistance Level $54.89 $0.15
Average True Range (ATR) 2.39 0.02
MACD 1.00 0.00
Stochastic Oscillator 80.15 70.60

Price Performance

Historical Comparison
BBW
KLTOW

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: